Retraction: MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway
Main Author: | Frontiers Editorial Office |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Physiology |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2022.1020568/full |
Similar Items
-
RETRACTED: MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway
by: Runze Wang, et al.
Published: (2021-04-01) -
Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy
by: Runze Wang, et al.
Published: (2021-04-01) -
Retraction: Ghrelin alleviates intestinal dysfunction in sepsis through the KLF4/MMP2 regulatory axis by activating SIRT1
by: Frontiers Editorial Office
Published: (2024-05-01) -
Retraction: Extracellular vesicles long non-coding RNA AGAP2-AS1 contributes to cervical cancer cell proliferation through regulating the miR-3064-5p/SIRT1 axis
by: Frontiers Editorial Office
Published: (2023-01-01) -
Retraction: The role of HOTAIR/miR-148b-3p/USF1 on regulating the permeability of BTB
by: Frontiers Editorial Office
Published: (2023-05-01)